We’ve got the skinny on what’s revving up and what’s sputtering…
P.S. For more stocks making moves, check out our new Zen Ratings Upgrades & Downgrades screener.
A note from our sponsors...
Hurry! Enter these 2 trades by EOD Tuesday The man behind THIS plan has used an odd twist on trading options for the past 20 years to rack up incredible profits... even using it personally to retire in just 10 years...with a $5.3 million "nest egg" that helped him sail worry-free through every Financial Crisis and market crash since... And now he's about to release his latest two trades... Click here to access your first two trades.
🔥 HOT: Gen Digital (NASDAQ: GEN) gained 7.7% by Friday’s close after an impressive earnings beat. The company turned in impressive numbers for the second quarter, beating its EPS and revenue predictions by 6.7% and 5.9%, respectively. It also raised its full-year guidance by a cool $100 million, increasing its estimated revenue range to between $4.8 billion and $4.9 billion from its previous estimate of between $4.7 billion and $4.8 billion. We rank GEN 11th out of 125 Software Infrastructure stocks we cover, and with a B rating in Value, adding it to your portfolio now is akin to a major discount, in our opinion. We give GEN a B Zen Rating and a Buy recommendation.
🥶 NOT: The Trade Desk (NASDAQ: TTD) got hit with a double dose of downgrades on Friday. Bank of America reduced its price target for the stock from $130 to $55, while RBC Capital took less drastic action by decreasing its price target for TTD to $90. The issue for both ratings firms seems to be The Trade Desk’s difficulty in signing new business. The company is hoping that its new CFO, Alex Kayyal, will be able to turn things around starting on August 21st, but Wall Street remains unconvinced. For our part, we feel that TTD’s Financials are too strong to write the stock off completely at this point. However, we’re still playing things safe by giving TTD a C Zen Rating and a Hold recommendation.
🔥 HOT: Gilead Sciences (NASDAQ: GILD) gained 8.3% on Friday after an earnings report that exceeded expectations and a guidance raise. The company’s EPS eked out a beat, coming in $0.05 per share higher than Wall Street’s expectation. Its revenue also outperformed projections by 1.4% ($100 million). A smattering of price target upgrades from ratings firms throughout the financial district helped GILD keep its momentum into the close. If you’re looking for a drug manufacturing stock to add to your investments, you can do a lot worse than GILD, in our opinion. The stock ranks seventh out of 18 stocks we cover in the industry, with B ratings in Value, Sentiment, and Financials. We give GILD a B Zen Rating and a Buy recommendation.
Find out more about our Financials metric here
🥶 NOT: Shares of Under Armour (NYSE: UAA) lost 18.1% on Friday after the company’s second-quarter earnings report failed to impress investors. The company’s quarterly EPS fell 20% short of consensus estimates, coming in at $0.02 per share compared to the consensus estimate of $0.025. Under Armour’s CEO, Kevin Plank, blamed the company’s poor performance and weak guidance on Trump’s tariffs and the associated uncertainty surrounding their future. He said that the tariffs, as they currently stand, cost his company an additional $100 million. Our research gives UAA D ratings in Sentiment and Momentum. UAA’s Growth potential isn’t much better (C rating), making it difficult to see how it earns a place in portfolios over the next few years. We give UAA a D Zen Rating and a Sell recommendation.
A note from our sponsors...
Trade Alert: Your First Two (Money Doubling?) Trades Jim Fink is about to issue two brand new trades designed to double their money (or more) in 3 to 10 days... and you're invited to get in on the action. I would caution you not to overlook this opportunity... Over the last 10 years (through multiple downturns) Jim has closed out 97% of his recommendations "in the green." His next two trades go live soon... if you want in you should make a move NOW. Claim your first two trades here.
What to Do Next?
Want to get in touch? Email us at news@wallstreetzen.com.